Some Antimicrobial Peptides Damage Human Cell Mitochondria — But PR-39 Doesn't

Cecropins, magainin, and melittin disrupted mitochondrial function, but PR-39 from pig intestine was nearly inert — critical safety data for antimicrobial peptide drug development.

Hugosson, M et al.·European journal of biochemistry·1994·Preliminary Evidencein-vitro
RPEP-00294In VitroPreliminary Evidence1994RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Cecropins, magainin, and melittin disrupted mitochondrial coupling, protein import, and respiration, while PR-39 was nearly inert toward mitochondria.

Key Numbers

How They Did This

Researchers isolated mitochondria and tested the effects of various antibacterial peptides on three functions: respiratory control (coupling), protein import, and respiration rates at increasing concentrations.

Why This Research Matters

If antimicrobial peptides damage human mitochondria, they could harm healthy cells. Finding that some peptides like PR-39 spare mitochondria helps guide the design of safer antimicrobial drugs.

The Bigger Picture

The biggest concern with antimicrobial peptide drugs is collateral damage to human cells. Finding that some peptides (like PR-39) spare mitochondria while others don't provides a safety roadmap for drug development.

What This Study Doesn't Tell Us

In vitro study using isolated mitochondria. Does not account for how peptides behave inside living cells where other factors affect their access to mitochondria.

Questions This Raises

  • ?What structural features make PR-39 safe for mitochondria?
  • ?Can other antimicrobial peptides be modified to reduce mitochondrial toxicity?

Trust & Context

Key Stat:
PR-39: nearly inert While cecropins and melittin severely disrupted mitochondria, PR-39 showed almost no mitochondrial toxicity — a crucial safety distinction
Evidence Grade:
Preliminary — in vitro study using isolated mitochondria. Provides safety comparisons but doesn't reflect whole-cell or in vivo toxicity.
Study Age:
Published in 1994 (32 years ago). Mitochondrial safety remains a key consideration in antimicrobial peptide drug development.
Original Title:
Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import.
Published In:
European journal of biochemistry, 223(3), 1027-33 (1994)
Database ID:
RPEP-00294

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why would antimicrobial peptides damage our own cells?

Antimicrobial peptides kill bacteria by disrupting their membranes. Human mitochondria evolved from ancient bacteria and still have similar membrane structures, making them vulnerable to the same membrane-disrupting mechanism.

Why is PR-39 different?

PR-39 kills bacteria through a different mechanism than membrane disruption — it may inhibit bacterial protein synthesis instead. This different mode of action means it doesn't attack mitochondrial membranes.

Read More on RethinkPeptides

Cite This Study

RPEP-00294·https://rethinkpeptides.com/research/RPEP-00294

APA

Hugosson, M; Andreu, D; Boman, H G; Glaser, E. (1994). Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import.. European journal of biochemistry, 223(3), 1027-33.

MLA

Hugosson, M, et al. "Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import.." European journal of biochemistry, 1994.

RethinkPeptides

RethinkPeptides Research Database. "Antibacterial peptides and mitochondrial presequences affect..." RPEP-00294. Retrieved from https://rethinkpeptides.com/research/hugosson-1994-antibacterial-peptides-and-mitochondrial

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.